Viewing Study NCT04814368


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-06-05 @ 2:51 AM
Study NCT ID: NCT04814368
Status: TERMINATED
Last Update Posted: 2025-10-24
First Post: 2021-03-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Knee Osteoarthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None canakinumab View
None LNA043 View
None knee View
None osteoarthritis View
None OA View
None joint pain View
None cartilage View
None MRI View
None DCE-MRI View
None KOOS View
None NRS Pain View
None IPAQ View